Lyka Labs Key Ratios
NSE: LYKALABS | BSE: 500259
₹75.57
₹0.00 (0.00%)As on 04-Nov-2026IST
Market cap
₹275 Cr
Revenue (TTM)
₹145 Cr
P/E Ratio
--
P/B Ratio
2.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 4.47 | 20.57 | 6.10 | 16.91 | -3.59 |
| EBIT | -42.03 | 131.34 | -271.57 | -199.78 | -157.72 |
| Net Profit | -37.77 | 138.27 | -307.96 | 13.61 | -161.28 |
| EPS | -37.73 | 138.30 | -306.99 | 21.04 | -159.37 |
| Book Value | -- | -- | -11.84 | 41.33 | 37.22 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 0.35 | 9.49 | -3.44 | -9.30 | 8.06 |
| Net Margin
| -7.40 | 0.27 | -3.31 | -7.91 | 5.64 |
| Return on equity
| -8.88 | -14.11 | -4.53 | -10.64 | 9.71 |
| Return on Capital
| -3.08 | 12.60 | -- | -5.96 | 10.01 |
| Return on Assets
| -4.94 | 2.14 | -2.80 | -5.95 | 4.76 |
| Debt to Equity (x)
| -- | -- | 0.22 | 0.53 | 0.36 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
-5.96
|
10.01
|
3.26
|
-1.00
|
|
Peer Median
|
--
|
5.28
|
0.21
|
-0.29
|
--
|
ROE
-4.53
Lower than Peers by 7.11
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-4.53
|
-10.64
|
9.71
|
-6.02
|
-63.63
|
|
Peer Median
|
2.58
|
0.78
|
-1.34
|
-0.26
|
--
|
ROA
-2.80
Lower than Peers by 3.54
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-2.80
|
-5.95
|
4.76
|
-1.70
|
-7.80
|
|
Peer Median
|
0.74
|
-0.08
|
-1.66
|
-3.42
|
--
|
EBIT Margin
-3.44
Lower than Peers by 10.58
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-3.44
|
-9.30
|
8.06
|
2.61
|
2.89
|
|
Peer Median
|
7.14
|
5.93
|
37.55
|
10.05
|
--
|
Net Margin
-3.31
Lower than Peers by 7.29
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-3.31
|
-7.91
|
5.64
|
-2.33
|
-13.63
|
|
Peer Median
|
3.98
|
0.04
|
-4.04
|
-7.43
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
-1.54
|
10.62
|
9.16
|
1.07
|
|
Peer Median
|
--
|
--
|
0.00
|
--
|
--
|
Revenue Growth
6.10
Higher than Peers by 2.07
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
6.10
|
-7.26
|
24.55
|
19.47
|
-52.05
|
|
Peer Median
|
4.04
|
9.22
|
216.49
|
-2.29
|
--
|
EBIT Growth
-271.57
Lower than Peers by 268.74
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-271.57
|
-206.98
|
284.61
|
7.82
|
-96.79
|
|
Peer Median
|
-2.82
|
-36.27
|
551.22
|
2.35
|
--
|
Net Profit Growth
-307.96
Lower than Peers by 303.43
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-307.96
|
-231.54
|
402.74
|
80.08
|
-134.21
|
|
Peer Median
|
-4.53
|
-92.74
|
295.65
|
-49.94
|
--
|
EPS Growth
-306.99
Lower than Peers by 283.76
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-306.99
|
-225.21
|
398.40
|
82.52
|
-131.67
|
|
Peer Median
|
-23.23
|
-93.11
|
302.24
|
50.00
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
-11.84
|
76.48
|
111.00
|
109.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.22
Higher than Peers by 0.08
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
0.22
|
0.53
|
0.36
|
0.96
|
2.58
|
|
Peer Median
|
0.14
|
0.21
|
0.17
|
0.31
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
0.21
|
0.14
|
0.17
|
0.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.16
Lower than Peers by 0.25
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
1.16
|
1.17
|
1.45
|
1.34
|
1.36
|
|
Peer Median
|
1.41
|
1.20
|
1.00
|
1.17
|
--
|
Quick Ratio
0.89
Lower than Peers by 0.25
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
0.89
|
0.92
|
1.18
|
1.09
|
1.21
|
|
Peer Median
|
1.14
|
2.71
|
1.35
|
1.05
|
--
|
Interest Coverage
-0.62
Lower than Peers by 2.37
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-0.62
|
-2.54
|
5.90
|
0.81
|
-0.11
|
|
Peer Median
|
1.75
|
1.71
|
0.40
|
0.13
|
--
|
Operating Efficiency
Debtors to sales
25.84
Lower than Peers by 0.93
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
25.84
|
27.28
|
31.10
|
24.28
|
21.62
|
|
Peer Median
|
26.77
|
24.51
|
146.71
|
25.11
|
--
|
Asset Turnover
0.83
Higher than Peers by 0.52
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
0.83
|
0.73
|
0.83
|
0.72
|
0.55
|
|
Peer Median
|
0.31
|
0.59
|
0.30
|
0.38
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
110.99
|
92.33
|
77.33
|
75.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
37.08
|
29.04
|
27.12
|
29.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
115.42
|
88.82
|
87.52
|
104.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
32.64
|
32.55
|
16.94
|
1.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-63.08
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
-63.08
|
--
|
44.97
|
--
|
--
|
|
Peer Median
|
--
|
--
|
46.29
|
--
|
--
|
Price / Book Value
2.87
Higher than Peers by 0.04
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
2.87
|
1.74
|
3.46
|
5.93
|
11.47
|
|
Peer Median
|
2.83
|
3.48
|
3.88
|
0.74
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
52.28
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
52.28
|
--
|
19.68
|
23.38
|
18.86
|
|
Peer Median
|
--
|
1.58
|
1.64
|
13.74
|
--
|
Market Cap
275
Higher than Peers by 113
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lyka Labs
|
275
|
160
|
360
|
351
|
321
|
|
Peer Median
|
162
|
100
|
131
|
213
|
--
|